Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.02024-01-01false0falsetruefalse 14606990 2024-01-01 2024-12-31 14606990 2023-01-01 2023-12-31 14606990 2024-12-31 14606990 2023-12-31 14606990 c:Director1 2024-01-01 2024-12-31 14606990 d:CurrentFinancialInstruments 2024-12-31 14606990 d:CurrentFinancialInstruments 2023-12-31 14606990 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 14606990 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 14606990 d:ShareCapital 2024-12-31 14606990 d:ShareCapital 2023-12-31 14606990 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 14606990 d:RetainedEarningsAccumulatedLosses 2024-12-31 14606990 d:RetainedEarningsAccumulatedLosses 2023-12-31 14606990 c:OrdinaryShareClass1 2024-01-01 2024-12-31 14606990 c:OrdinaryShareClass1 2024-12-31 14606990 c:OrdinaryShareClass2 2024-01-01 2024-12-31 14606990 c:OrdinaryShareClass2 2024-12-31 14606990 c:OrdinaryShareClass3 2024-01-01 2024-12-31 14606990 c:OrdinaryShareClass3 2024-12-31 14606990 c:OrdinaryShareClass4 2024-01-01 2024-12-31 14606990 c:OrdinaryShareClass4 2024-12-31 14606990 c:OrdinaryShareClass5 2024-01-01 2024-12-31 14606990 c:OrdinaryShareClass5 2023-12-31 14606990 c:FRS102 2024-01-01 2024-12-31 14606990 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 14606990 c:FullAccounts 2024-01-01 2024-12-31 14606990 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14606990 6 2024-01-01 2024-12-31 14606990 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 14606990










BELLEROSE INVESTMENTS LIMITED

UNAUDITED
FINANCIAL STATEMENTS

FOR THE YEAR ENDED
31 DECEMBER 2024
 






 



 






 
BELLEROSE INVESTMENTS LIMITED
REGISTERED NUMBER:14606990

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
1,125,000
-

Current assets
  

Debtors: amounts falling due within one year
 5 
242
100

Cash at bank and in hand
 6 
1,798
-

  
2,040
100

Current liabilities
  

Creditors: amounts falling due within one year
 7 
(1,130,166)
-

Net current (liabilities)/assets
  
 
 
(1,128,126)
 
 
100

Total assets less current liabilities
  
(3,126)
100

  

Net (liabilities)/assets
  
(3,126)
100


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
 9 
(3,226)
-

Shareholders (deficit)/funds
  
(3,126)
100


The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Mr T J White
Director

Date: 29 September 2025

The notes on pages 3 to 7 form part of these financial statements.
Page 1

 
BELLEROSE INVESTMENTS LIMITED
REGISTERED NUMBER:14606990

STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024


Page 2

 
BELLEROSE INVESTMENTS LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Bellerose Investments Limited is a private company, limited by shares and incorporated in England and Wales, registration number 14606990. The registered office address 11 Killieser Avenue, London, SW2 4NU. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies.

The financial statements are presented in sterling which the function currency of the Company and rounded to the nearest £.

The following principal accounting policies have been applied:

  
2.2

Compliance with accounting standard

The financial statements have been prepared in accordance with the provisions of FRS102. There have been no material departures from the standard.

 
2.3

Going concern

The Company was loss making in the period and in a net liability position at the year end date. The financial statements have been prepared on a going concern basis which means that the Company can be expected to meet its liabilities as they fall due for a period of 12 months from the date of signing these financial statements. In assessing the appropriateness of the going concern basis of preparation the Directors have taken into account the key risks of the business as well as the Company's business model and the availability of cash resources.
 
The Directors have confirmed that the Company will continue to operate for a period of at least 12 months from the date of signing these financial statements. On this basis, the Directors consider it appropriate to prepare the financial statements on a going concern basis.

 
2.4

Valuation of investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
BELLEROSE INVESTMENTS LIMITED
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Page 4

 
BELLEROSE INVESTMENTS LIMITED
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.8
Financial instruments (continued)

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


3.


Employees

The Company has no employees other than the Directors, who did not receive any remuneration (2023 - £NIL).




4.


Fixed asset investments





Unlisted investments

£



Cost or valuation


Additions
1,125,000



At 31 December 2024
1,125,000




Page 5

 
BELLEROSE INVESTMENTS LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Debtors

2024
2023
£
£


Other debtors
242
100



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
1,798
-



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
1,128,151
-

Accruals and deferred income
2,015
-

1,130,166
-





8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



25 (2023 - 0) A Ordinary shares of £1.00 each
25
-
25 (2023 - 0) B Ordinary shares of £1.00 each
25
-
25 (2023 - 0) C Ordinary shares of £1.00 each
25
-
25 (2023 - 0) D Ordinary shares of £1.00 each
25
-
0 (2023 - 100) Ordinary shares of £1.00 each
-
100

100

100



9.


Reserves

Profit and loss account

The profit and loss account represents cumulative profits and losses net of dividends and other adjustments.

Page 6

 
BELLEROSE INVESTMENTS LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Transactions with directors

During the year the Director provided loans to the Company of £1,128,251 (2023 - £NIL). At the balance sheet date, an amount of £1,128,151 (2023 - £NIL) was owed to the Director. This balance is interest free, repayable on demand and included in other creditors.


Page 7